City

Minneapolis (1)

Rochester (1)

Saint Louis (1)

San Francisco (1)

Condition

Myeloid and Monocytic Leukemia (2)

Acute Myeloid Leukemia (1)

Bone and Joints (1)

Brain and Nervous System (1)

Leukemia, NOS (1)

Lymphoid Leukemia (1)

Myelodysplastic Syndromes (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Masonic Cancer Center, University of Minnesota (1)

Stanford University (1)

Collaborator

Incyte Corporation (1)

Intervention

decitabine (1)

donor lymphocyte infusion (dli) (1)

gold program (1)

ruxolitinib (1)

treatment as usual (tau) (1)

Study Documents

Intervention Type

behavioral (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

myeloid and monocytic leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed

Acute Myeloid Leukemia
+2 more

Decitabine
+2 more

Minneapolis, Minnesota
+2 more

Nov 2, 2022

Bone and Joints, Brain and Nervous System, Leukemia, NOS Trial in San Francisco (GOLD Program, Treatment as usual (TAU))

Recruiting

Bone and Joints
+4 more

GOLD Program
Treatment as usual (TAU)

San Francisco, California

Stanford Cancer Institute

Jun 8, 2022